Valuation: Conavi Medical Corp.

Market Cap 20.01M 14.02M 12.55M 11.7M 10.61M 1.34B 20.13M 141M 55.02M 691M 52.65M 51.48M 2.22B P/E 2024 *
-
P/E 2025 -1.88x
Enterprise Value 34.07M 23.87M 21.37M 19.92M 18.07M 2.28B 34.29M 239M 93.7M 1.18B 89.66M 87.67M 3.79B EV / Sales 2024 *
-
EV / Sales 2025 7.18x
Free-Float
67.37%
Yield 2024 *
-
Yield 2025 -
1 day-15.22%
1 week-21.68%
Current month-19.77%
1 month-31.01%
3 months-51.05%
6 months-68.90%
Current year-74.89%
1 week 0.08
Extreme 0.08
0.12
1 month 0.08
Extreme 0.08
0.12
Current year 0.08
Extreme 0.08
0.43
1 year 0.08
Extreme 0.08
0.56
3 years 0
Extreme 0.0007
1
5 years 0
Extreme 0.0007
1
10 years 0
Extreme 0.0007
1
Change 5-day change 1-year change 3-year change Capi.($)
-15.22%-21.68% - - 14.02M
+0.64%-2.15%+26.19%+37.23% 245B
+0.63%-0.00%+9.26%+5.59% 156B
+0.87%+5.21%-0.45%+60.69% 151B
+2.60%+3.40%-54.05%-9.87% 63.53B
+1.38%-0.96%+16.84%+23.56% 49.8B
+0.61%+4.81%-15.68%-16.04% 49.28B
+0.46%+0.02%+25.41%+57.27% 48.3B
-0.09%+4.37%+3.23%+36.99% 47.9B
-0.38%-1.82%+30.54%+72.15% 42.45B
Average -0.92%+2.26%+4.59%+29.73% 94.74B
Weighted average by Cap. +0.63%+1.94%+8.32%+31.09%

Financials

2024 2025
Net sales 2.16M 1.51M 1.36M 1.26M 1.15M 145M 2.17M 15.18M 5.94M 74.67M 5.69M 5.56M 240M 9.12M 6.39M 5.72M 5.33M 4.84M 611M 9.18M 64.08M 25.08M 315M 24M 23.47M 1.01B
Net income -43.62M -30.55M -27.35M -25.49M -23.12M -2.92B -43.89M -306M -120M -1.51B -115M -112M -4.85B -20.52M -14.37M -12.86M -11.99M -10.88M -1.37B -20.64M -144M -56.42M -709M -53.98M -52.79M -2.28B
Net Debt 82.74M 57.96M 51.88M 48.37M 43.87M 5.54B 83.26M 581M 228M 2.86B 218M 213M 9.2B 14.06M 9.85M 8.82M 8.22M 7.46M 942M 14.15M 98.8M 38.68M 486M 37.01M 36.19M 1.56B
Projected Income Statement - Annual - Conavi Medical Corp.
Logo Conavi Medical Corp.
Conavi Medical Corp. is a Canada-based medical device company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Employees
-
Date Price Change Volume
26-10-12 US$0.0830 -15.22% 104,883
26-10-09 US$0.0979 -7.87% 13,388
26-10-08 US$0.1063 +0.82% 35,354
26-10-07 US$0.1054 +5.40% 22,081
26-10-06 US$0.1000 -5.64% 3,853
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1450CAD
Average target price
1.300CAD
Spread / Average Target
+796.55%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Conavi Medical Corp.